PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsReplens
Replens
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
123 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248K59.0121316
Irritable bowel syndromeD043183EFO_0000555K582111014
Type 2 diabetes mellitusD003924EFO_0001360E11257
HypercholesterolemiaD006937167
SyndromeD01357721137
HyperlipidemiasD006949EFO_0003774E78.51113
DiarrheaD003967R19.71113
InfertilityD007246EFO_0000545112
Urinary incontinenceD014549R32112
DyslipidemiasD05017111
Show 4 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fecal incontinenceD005242R153247
Cardiovascular diseasesD002318EFO_0000319I98156
DyspareuniaD004414N94.1112
Heart diseasesD006331EFO_0003777I51.9112
Rectal neoplasmsD012004112
Low anterior resection syndromeD000094123112
Bacterial conjunctivitisD003234EFO_1000829H10.011
ConjunctivitisD003231H1011
AtrophyD00128411
MenopauseD008593EFO_0003922N9511
Show 17 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9178
Breast neoplasmsD001943EFO_0003869C501225
Metabolic syndromeD024821EFO_0000195E88.810145
Healthy volunteers/patients1113
Male breast neoplasmsD018567112
Ulcerative colitisD003093EFO_0000729K51112
ColitisD003092EFO_0003872K52.9112
Intestinal diseasesD007410K63.9112
Atrophic vaginitisD059268EFO_100127111
PostmenopauseD01769811
Show 10 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Congenital abnormalitiesD000013EFO_0003915Q89.911
Urinary tract infectionsD014552EFO_0003103N39.011
Urogenital abnormalitiesD01456411
DysuriaD053159EFO_0003901R3011
HemochromatosisD006432EFO_1000642E83.1111
HemosiderosisD00648611
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OverweightD050177E66.355
Diabetes mellitusD003920EFO_0000400E08-E1355
Body weightD001835EFO_000433844
Heart disease risk factorsD00008274233
Healthy dietD00007200133
Kidney diseasesD007674EFO_0003086N0833
Weight lossD01543133
Digestive signs and symptomsD01281722
Chronic kidney failureD007676EFO_0003884N18.622
Renal dialysisD006435EFO_0010690Z99.222
Show 57 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
12 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use